Securities and Exchange Board of India (SEBI) has imposed Rs 6 lakh fine on Piramal Enterprises and five of its senior officials, including Ajay and Swati Piramal, for violating insider trading rules. This was with regard to the $3.72 billion sale of the company’s domestic healthcare business to Abbott Laboratories in May 2010. SEBI during its probe found that entities failed to handle the Unpublished Price Sensitive Information of the above transaction on a ‘need to know’ basis as Anand Piramal, who was neither an employee nor a director, was privy to the decision at every stage and thus violated the SEBI norms.
Piramal Enterprises (PEL) is engaged in the business of pharmaceuticals, including research and development, financial services and information management through its subsidiaries.
| Company Name | CMP |
|---|---|
| Bajaj Finance | 980.65 |
| Shriram Finance | 1004.00 |
| Aditya Birla Capital | 369.25 |
| Chola Invest & Fin. | 1710.95 |
| Tata Capital | 328.45 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: